Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial (Q33419580)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial |
scientific article |
Statements
1 reference
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial (English)
1 reference
Christian H Geisler
1 reference
Jade Jones
1 reference
Stefania Pittaluga
1 reference
Maryalice Stetler-Stevenson
1 reference
Mohammed Z H Farooqui
1 reference
Janet Valdez
1 reference
Sabrina Martyr
1 reference
Georg Aue
1 reference
Nakhle Saba
1 reference
Sarah E M Herman
1 reference
Xin Tian
1 reference
Gerald Marti
1 reference
Susan Soto
1 reference
Thomas E Hughes
1 reference
Andrew Lipsky
1 reference
Constance Yuan
1 reference
Yuh Shan Lee
1 reference
Lone B Pedersen
1 reference
Katherine R Calvo
1 reference
Diane C Arthur
1 reference
Irina Maric
1 reference
Richard Childs
1 reference
Neal S Young
1 reference
Adrian Wiestner
1 reference
31 December 2014
1 reference
1 reference
16
1 reference
169-176
1 reference
Identifiers
1 reference
1 reference
1 reference